These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12419014)

  • 1. Metabolism of zaleplon by human liver: evidence for involvement of aldehyde oxidase.
    Lake BG; Ball SE; Kao J; Renwick AB; Price RJ; Scatina JA
    Xenobiotica; 2002 Oct; 32(10):835-47. PubMed ID: 12419014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of zaleplon metabolism by cimetidine in the human liver: in vitro studies with subcellular fractions and precision-cut liver slices.
    Renwick AB; Ball SE; Tredger JM; Price RJ; Walters DG; Kao J; Scatina JA; Lake BG
    Xenobiotica; 2002 Oct; 32(10):849-62. PubMed ID: 12419015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of Zaleplon by human hepatic microsomal cytochrome P450 isoforms.
    Renwick AB; Mistry H; Ball SE; Walters DG; Kao J; Lake BG
    Xenobiotica; 1998 Apr; 28(4):337-48. PubMed ID: 9604298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability of Zaleplon 5-Oxidase Activity in Mice and Humans, and Inhibition by Raloxifene.
    Tanoue C; Sugihara K; Tayama Y; Uramaru N; Watanabe Y; Ohta S; Kitamura S
    Drug Metab Lett; 2017; 10(4):278-285. PubMed ID: 28029084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldehyde oxidase-dependent marked species difference in hepatic metabolism of the sedative-hypnotic, zaleplon, between monkeys and rats.
    Kawashima K; Hosoi K; Naruke T; Shiba T; Kitamura M; Watabe T
    Drug Metab Dispos; 1999 Mar; 27(3):422-8. PubMed ID: 10064576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of human metabolism of the sedative-hypnotic zaleplon using chimeric mice transplanted with human hepatocytes.
    Tanoue C; Sugihara K; Uramaru N; Tayama Y; Watanabe Y; Horie T; Ohta S; Kitamura S
    Xenobiotica; 2013 Nov; 43(11):956-62. PubMed ID: 23651075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strain difference of oxidative metabolism of the sedative-hypnotic zaleplon by aldehyde oxidase and cytochrome P450 in vivo and in vitro in rats.
    Tanoue C; Sugihara K; Uramaru N; Watanabe Y; Tayama Y; Ohta S; Kitamura S
    Drug Metab Pharmacokinet; 2013; 28(3):269-73. PubMed ID: 23358259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydralazine as a selective probe inactivator of aldehyde oxidase in human hepatocytes: estimation of the contribution of aldehyde oxidase to metabolic clearance.
    Strelevitz TJ; Orozco CC; Obach RS
    Drug Metab Dispos; 2012 Jul; 40(7):1441-8. PubMed ID: 22522748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of mammalian liver cytosols and aldehyde oxidase in reductive metabolism of zonisamide.
    Sugihara K; Kitamura S; Tatsumi K
    Drug Metab Dispos; 1996 Feb; 24(2):199-202. PubMed ID: 8742231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of a novel phosphodiesterase-IV inhibitor (V11294) by human hepatic cytochrome P450 forms.
    Subrahmanyam V; Renwick AB; Walters DG; Price RJ; Tonelli AP; Lake BG
    Xenobiotica; 2002 Jun; 32(6):521-34. PubMed ID: 12160484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Inhibition of Human Aldehyde Oxidase Activity by Clinically Relevant Concentrations of Gefitinib and Erlotinib: Comparison with Select Metabolites, Molecular Docking Analysis, and Impact on Hepatic Metabolism of Zaleplon and Methotrexate.
    Tan WK; Tan ARY; Sivanandam P; Goh EJH; Yap ZP; Saburulla NF; Austin-Muttitt K; Mullins JGL; Lau AJ
    J Pharmacol Exp Ther; 2020 Aug; 374(2):295-307. PubMed ID: 32393528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of 7-benzyloxy-4-trifluoromethyl-coumarin by human hepatic cytochrome P450 isoforms.
    Renwick AB; Surry D; Price RJ; Lake BG; Evans DC
    Xenobiotica; 2000 Oct; 30(10):955-69. PubMed ID: 11315104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-substituted phthalazines as probes of the substrate-binding site of mammalian molybdenum hydroxylases.
    Beedham C; Bruce SE; Critchley DJ; Rance DJ
    Biochem Pharmacol; 1990 Apr; 39(7):1213-21. PubMed ID: 2322306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate specificity of human liver aldehyde oxidase toward substituted quinazolines and phthalazines: a comparison with hepatic enzyme from guinea pig, rabbit, and baboon.
    Beedham C; Critchley DJ; Rance DJ
    Arch Biochem Biophys; 1995 Jun; 319(2):481-90. PubMed ID: 7786031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cynomolgus monkey liver aldehyde oxidase: extremely high oxidase activity and an attempt at purification.
    Sugihara K; Katsuma Y; Kitamura S; Ohta S; Fujitani M; Shintani H
    Comp Biochem Physiol C Toxicol Pharmacol; 2000 May; 126(1):53-60. PubMed ID: 11048665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldehyde oxidase-catalysed oxidation of methotrexate in the liver of guinea-pig, rabbit and man.
    Jordan CG; Rashidi MR; Laljee H; Clarke SE; Brown JE; Beedham C
    J Pharm Pharmacol; 1999 Apr; 51(4):411-8. PubMed ID: 10385213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time Course of Aldehyde Oxidase and Why It Is Nonlinear.
    Abbasi A; Paragas EM; Joswig-Jones CA; Rodgers JT; Jones JP
    Drug Metab Dispos; 2019 May; 47(5):473-483. PubMed ID: 30787100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatic oxidation of phthalazine with guinea pig liver aldehyde oxidase and liver slices: inhibition by isovanillin.
    Panoutsopoulos GI; Beedham C
    Acta Biochim Pol; 2004; 51(4):943-51. PubMed ID: 15625566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rat and human liver cytochrome P-450 isoform metabolism of ecteinascidin 743 does not predict gender-dependent toxicity in humans.
    Reid JM; Kuffel MJ; Ruben SL; Morales JJ; Rinehart KL; Squillace DP; Ames MM
    Clin Cancer Res; 2002 Sep; 8(9):2952-62. PubMed ID: 12231541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
    Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A
    Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.